A preclinical evaluation of the efficacy and safety of SIN-EFS-IL2RG.co vector, a self-inactivating lentiviral vector (SIN-LV) carrying #IL2RG, to potentiate GMP-compliant #GeneTherapy in #XSCID. #medsky
#MostRead #OpenAccess:
www.sciencedirect.com/science/arti...